![A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients]()
A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patientsLaquente, Berta; Lopez-Martin, Jose; Richards, Donald; Illerhaus, Gerald; Chang, David Z.; Kim, George; Stella, Philip; Richel, Dirk; Szcylik, Cezary; Cascinu, Stefano; Frassineti, G. L.; Ciuleanu, Tudor; Hurt, Karla; Hynes, Scott; Lin, Ji; Lin, Aimee Bence; Von Hoff, Daniel; Calvo, Emiliano · BMC Cancer · 2017